Laboratory Evaluation of FR10024, a New Cephalosporin Derivative

FR10024 is a broad-spectrum antibiotic. The in vitro antibacterial activity of FR10024 against clinical isolates of Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis is greater than that of any of the cephalosporins developed to date. Indole-positive Proteus, Ente...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	Antimicrob Agents Chemother
Egile Nagusiak:	Nishida, Minoru, Murakawa, Takeo, Kamimura, Toshiaki, Okada, Naohiko, Fukada, Shigemi, Sakamoto, Hiroshi, Nakamoto, Shoji, Yokota, Yoshiko, Kono, Yoko
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Microbiology (ASM) 1977
Gaiak:	Pharmacology and Therapeutics
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC351918/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/836014/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.11.1.51
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!